Real-World Observational Study on Patient-Reported Outcomes in the Treatment of Insomnia with Daridorexant in Canada

A Study of Daridorexant in Chinese Patients With Insomnia Disorder

NCT06010693 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Daridorexant in Participants With Insomnia Disorder

NCT07028697 ·Status: COMPLETED ·Phase: PHASE3

The Effects of Lemborexant on the Ability to Sleep During Daytime

NCT06231641 ·Status: TERMINATED ·Phase: PHASE2

A Study of the Effect of Daridorexant on Nighttime Body Posture, the Noise Level Required to Wake up, and the Ability to Remember Words Previously Presented

NCT05702177 ·Status: COMPLETED ·Phase: PHASE1

Lemborexant for the Treatment of Residual Insomnia in Major Depressive Disorder (MDD)

NCT06843187 ·Status: RECRUITING ·Phase: PHASE2

Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial

NCT06093126 ·Status: RECRUITING ·Phase: PHASE4

A Dual Orexin Receptor Antagonist to Reduce Biomarkers of Neurodegeneration in Adults With Insomnia.

NCT06823752 ·Status: RECRUITING ·Phase: PHASE2

Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Healthy Subjects and Adult and Elderly Subjects With Mild Obstructive Sleep Apnea

NCT03471871 ·Status: COMPLETED ·Phase: PHASE1

Long-term Study of Lemborexant in Insomnia Disorder (SUNRISE 2)

NCT02952820 ·Status: COMPLETED ·Phase: PHASE3

Study to Investigate Safety, Tolerability, Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteers

NCT01030939 ·Status: COMPLETED ·Phase: PHASE1

A Six Week, Double-Blind Randomized, Efficacy and Safety, Sleep Lab Trial With Esmirtazapine (Org 50081) (P05707)

NCT00506389 ·Status: COMPLETED ·Phase: PHASE3

Almorexant in Primary Insomnia

NCT00640848 ·Status: COMPLETED ·Phase: PHASE1

Sodium Oxybate in Idiopathic Hypersomnia

NCT03597555 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients with Severe Insomnia

NCT06053840 ·Status: COMPLETED ·Phase: PHASE4

Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia

NCT00608985 ·Status: COMPLETED ·Phase: PHASE3

Study to Validate the Questionnaire Called IDSIQ™ in Patients With Insomnia Disorder

NCT03056053 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Suvorexant in the Treatment of Hot Flash-associated Insomnia

NCT03034018 ·Status: COMPLETED ·Phase: PHASE4

Treating Insomnia and Improving Metabolic Health in Midlife Women With Insomnia

NCT05593653 ·Status: COMPLETED ·Phase: PHASE4

To Evaluate The Effects Of SB-649868 (10, 30 Mg And 60 Mg) On Subjects With Primary Insomnia

NCT00426816 ·Status: COMPLETED ·Phase: PHASE2

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Bayesian Adaptive Randomization Design, Dose Response Study of the Efficacy of E2006 in Adults and Elderly Subjects With Chronic Insomnia

NCT01995838 ·Status: COMPLETED ·Phase: PHASE2

Insomnia and Daytime Function in Osteoarthritis

NCT00530556 ·Status: COMPLETED ·Phase: PHASE4

Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress

NCT03642028 ·Status: RECRUITING ·Phase: PHASE4

Study to Evaluate the Effect of 2 Dosage Strengths of Lemborexant (E2006) on a Multiple Sleep Latency Test in Participants With Insomnia Disorder

NCT02350309 ·Status: COMPLETED ·Phase: PHASE1

Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)

NCT02783729 ·Status: COMPLETED ·Phase: PHASE3

A Study of Lemborexant in Chinese Participants With Insomnia Disorder

NCT04549168 ·Status: COMPLETED ·Phase: PHASE3